Publications

  1. Bullock C, McCann M, Sharma A, Young JR, Metcalfe AM, Parent EE. FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis. Radiol Case Rep. 2023 Nov; 18 (11):3932-3935 Epub 2023 Aug 28
    View PubMed
  2. Gococo-Benore DA, Kuhlman J, Parent EE, Sharma A, Accurso J, Yang M, Kendi AT, Johnson G, Sonbol MB, Hobday T, Halfdanarson TR, Starr J. Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden. J Nucl Med. 2023 Jun; 64 (6):880-884 Epub 2023 Apr 20
    View PubMed
  3. Orciuolo J, Sharma A, Parent EE, Accurso JM, Jain MK, Young JR. Incidental Airway Findings on PET/CT with (18)F-PSMA. J Nucl Med. 2023 Jun; 64 (6):993 Epub 2023 Jan 05
    View PubMed
  4. Khan MA, Jennings JW, Baker JC, Smolock AR, Shah LM, Pinchot JW, Wessell DE, Kim CY, Lenchik L, Parsons MS, Huhnke G, Shek-Man Lo S, Lu Y, Potter C, Reitman C, Sahgal A, Sharma A, Yalla NM, Beaman FD, Kapoor BS, Burns J, Expert Panels on Neurological Imaging, Interventional Radiology, and Musculoskeletal Imaging. ACR Appropriateness Criteria(R) Management of Vertebral Compression Fractures: 2022 Update. J Am Coll Radiol. 2023 May; 20 (5S):S102-S124
    View PubMed
  5. Subhas N, Wu F, Fox MG, Nacey N, Aslam F, Blankenbaker DG, Caracciolo JT, DeJoseph DA, Frick MA, Jawetz ST, Said N, Sandstrom CK, Sharma A, Stensby JD, Walker EA, Chang EY, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria(R) Chronic Extremity Joint Pain-Suspected Inflammatory Arthritis, Crystalline Arthritis, or Erosive Osteoarthritis: 2022 Update. J Am Coll Radiol. 2023 May; 20 (5S):S20-S32
    View PubMed
  6. Jawetz ST, Fox MG, Blankenbaker DG, Caracciolo JT, Frick MA, Nacey N, Said N, Sharma A, Spence S, Stensby JD, Subhas N, Tubb CC, Walker EA, Yu F, Beaman FD, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria(R) Chronic Hip Pain: 2022 Update. J Am Coll Radiol. 2023 May; 20 (5S):S33-S48
    View PubMed
  7. Brahmbhatt P, Ataei F, Parent EE, Sharma A. Atypically Intense Pharmacologically Induced Brown Fat Activation on FDG PET/CT. Clin Nucl Med. 2023 Mar 1; 48 (3):233-236 Epub 2023 Jan 10
    View PubMed
  8. Ha AS, Chang EY, Bartolotta RJ, Bucknor MD, Chen KC, Ellis HB Jr, Flug J, Leschied JR, Ross AB, Sharma A, Thomas JM, Beaman FD, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria(R) Osteonecrosis: 2022 Update. J Am Coll Radiol. 2022 Nov; 19 (11S):S409-S416
    View PubMed
  9. Pierce JL, Perry MT, Wessell DE, Lenchik L, Ahlawat S, Baker JC, Banks J, Caracciolo JT, DeGeorge KC, Demertzis JL, Garner HW, Scott JA, Sharma A, Beaman FD, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria(R) Suspected Osteomyelitis, Septic Arthritis, or Soft Tissue Infection (Excluding Spine and Diabetic Foot): 2022 Update. J Am Coll Radiol. 2022 Nov; 19 (11S):S473-S487
    View PubMed
  10. Ataei F, Sharma A, Stanborough R, Parent EE. FDG PET-MRI evaluation of synchronous gallbladder adenocarcinoma and POEMS syndrome. Radiol Case Rep. 2022 Nov; 17 (11):4294-4298 Epub 2022 Sept 13
    View PubMed
  11. Stanborough R, Demertzis JL, Wessell DE, Lenchik L, Ahlawat S, Baker JC, Banks J, Caracciolo JT, Garner HW, Hentz C, Lewis VO, Lu Y, Maynard JR, Pierce JL, Scott JA, Sharma A, Beaman FD, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria(R) Malignant or Aggressive Primary Musculoskeletal Tumor-Staging and Surveillance: 2022 Update. J Am Coll Radiol. 2022 Nov; 19 (11S):S374-S389
    View PubMed
  12. Gococo-Benore DA, Parent E, Sharma A, Accurso J, Yang M, Kendi AT, Sonbol B, Halfdanarson TR, Starr JS. Hepatotoxicity from peptide receptor radionuclide therapy (prrt) in neuroendocrine tumors (nets) patients with very high liver tumor burden. Pancreas. 2022; 51(3):E47.
  13. Sharma A, Navaz AJ, Pandey MK, Parent EE. Unusual Increased Blood Pool Activity on 68Ga-DOTATATE PET/CT in a Patient With Metastatic Neuroendocrine Disease. Clin Nucl Med. 2022 Feb 1; 47 (2):137-139
    View PubMed
  14. Panda A, Sharma A, Dundar A, Packard A, Aase L, Kotsenas A, Kendi AT. Twitter Use by Academic Nuclear Medicine Programs: Pilot Content Analysis Study. JMIR Form Res. 2021 Nov 08; 5(11):e24448.
    View PubMed
  15. Advani P, Chumsri S, Pai T, Li Z, Sharma A, Parent E. Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients. Ann Nucl Med. 2021 Nov; 35 (11):1264-1269 Epub 2021 Aug 31
    View PubMed
  16. Rao CK, Tatum WO, Brinkmann BH, Sharma A, Yelvington KH, Sirven JI, Ritaccio AL, McKay JH, Feyissa AM. Injection of prophylactic lorazepam versus antiseizure drugs on the localization value of ictal SPECT studies and treatment-emergent adverse events: A single-center prospective study. Epilepsy Behav. 2021 Feb; 115:107500. Epub 2020 Dec 13.
    View PubMed
  17. Bailey R, Sharma A, Parent EE. Carney-Stratakis Syndrome presenting as occult mediastinal paraganglioma. Radiol Case Rep. 2020 Sep; 15 (9):1528-1531 Epub 2020 July 04
    View PubMed
  18. Agely A, Sharma A, Parent EE, Nawaz A, Jain MK. Isolated Intravascular Prostate Carcinoma Recurrence Confirmed With 18F-Fluciclovine PET/CT and MRI. Clin Nucl Med. 2020 Jun; 45 (6):442-443
    View PubMed
  19. Core JM, Frey GT, Sharma A, Bussone ST, Legout JD, McKinney JM, Lewis AR, Ritchie C, Devcic Z, Paz-Fumagalli R, Toskich BB. Increasing Yttrium-90 Dose Conformality Using Proximal Radioembolization Enabled by Distal Angiosomal Truncation for the Treatment of Hepatic Malignancy. J Vasc Interv Radiol. 2020 Jun; 31 (6):934-942 Epub 2020 May 04
    View PubMed
  20. Bestic JM, Wessell DE, Beaman FD, Cassidy RC, Czuczman GJ, Demertzis JL, Lenchik L, Motamedi K, Pierce JL, Sharma A, Sloan AE, Than K, Walker EA, Ying-Kou Yung E, Kransdorf MJ, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria(R) Primary Bone Tumors. J Am Coll Radiol. 2020 May; 17 (5S):S226-S238
    View PubMed
  21. Holliday RM, Jain MK, Accurso JM, Sharma A, Harrison SR, Aloszka DL, Bowman AW. Buffering the Suffering of Breast Lymphoscintigraphy. J Nucl Med Technol. 2020 Mar; 48 (1):51-53 Epub 2019 June 10
    View PubMed
  22. Starr JS, Sonbol MB, Hobday TJ, Sharma A, Kendi AT, Halfdanarson TR. Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights. Onco Targets Ther. 2020; 13:3545-3555 Epub 2020 Apr 28
    View PubMed
  23. Walker EA, Beaman FD, Wessell DE, Cassidy RC, Czuczman GJ, Demertzis JL, Lenchik L, Motamedi K, Pierce JL, Sharma A, Ying-Kou Yung E, Kransdorf MJ, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria(R) Suspected Osteomyelitis of the Foot in Patients With Diabetes Mellitus. J Am Coll Radiol. 2019 Nov; 16 (11S):S440-S450
    View PubMed
  24. Torabi M, Lenchik L, Beaman FD, Wessell DE, Bussell JK, Cassidy RC, Czuczman GJ, Demertzis JL, Khurana B, Klitzke A, Motamedi K, Pierce JL, Sharma A, Walker EA, Kransdorf MJ, Expert Panel on Musculoskeletal Imaging:. ACR Appropriateness Criteria((R)) Acute Hand and Wrist Trauma. J Am Coll Radiol. 2019 May; 16 (5S):S7-S17
    View PubMed
  25. Parent E, Sharma A, Jain M. Amino Acid PET Imaging of Glioma Current Radiology Reports. April 2019; 7(5).
  26. Kasi PM, Sharma A, Jain MK. Expanding the Indication for Novel Theranostic 177Lu-Dotatate Peptide Receptor Radionuclide Therapy: Proof-of-Concept of PRRT in Merkel Cell Cancer. Case Rep Oncol. 2019 Jan-Apr; 12 (1):98-103 Epub 2019 Jan 21
    View PubMed
  27. Kasi PM, Maige CL, Shahjehan F, Rodgers JM, Aloszka DL, Ritter A, Andrus ML, Mcmillan JM, Mody K, Sharma A, Jain MK. A Care Process Model to Deliver (177)Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors. Front Oncol. 2018; 8:663 Epub 2019 Jan 09
    View PubMed
  28. Kransdorf MJ, Murphey MD, Wessell DE, Cassidy RC, Czuczman GJ, Demertzis JL, Lenchik L, Motamedi K, Pierce JL, Sharma A, Walker EA, Ying-Kou Yung E, Beaman FD, Expert Panel on Musculoskeletal Imaging:. ACR Appropriateness Criteria((R)) Soft-Tissue Masses. J Am Coll Radiol. 2018 May; 15 (5S):S189-S197
    View PubMed
  29. Hassanzadeh C, Rao YJ, Chundury A, Rowe J, Ponisio MR, Sharma A, Miller-Thomas M, Tsien CI, Ippolito JE. Multiparametric MRI and [(18)F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma. Front Oncol. 2017; 7:178 Epub 2017 Aug 18
    View PubMed
  30. Sotoudeh H, Sharma A, Fowler KJ, McConathy J, Dehdashti F. Clinical application of PETMRI in oncology. J Magn Reson Imaging. 2016 Aug; 44: (2)265-76.
    View PubMed
  31. Fowler KJ, Maughan NM, Laforest R, Saad NE, Sharma A, Olsen J, Speirs CK, Parikh PJ. PETMRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response. Cardiovasc Intervent Radiol. 2016 Jun; 39: (6)855-64.
    View PubMed
  32. Su Y, Rubin BB, McConathy J, Laforest R, Qi J, Sharma A, Priatna A, Benzinger TL. Impact of MR-Based Attenuation Correction on Neurologic PET Studies. J Nucl Med. 2016 Jun; 57: (6)913-7.
    View PubMed
  33. Wright CL, Sharma A. Unusual appearance for urinary bladder obstruction detected with 99mTc-MDP bone scintigraphy. Clin Nucl Med. 2015 Dec; 40: (12)967-8.
    View PubMed
  34. Jain R, Sharma A, Uliel L, Mellnick V, McConathy J. An overview of nuclear medicine studies for urgent and emergent indications. Semin Roentgenol. 2014 Apr; 49: (2)210-24.
    View PubMed
  35. Sharma A, McConathy J. Overview of PET Tracers for Brain Tumor Imaging. PET Clin. 2013 Apr; 8: (2)129-46.
    View PubMed
  36. Agrawal G, Wright CL, Rhodes NG, Sharma A. Mismatched perfusion defects secondary to recent methyl methacrylate embolization. Clin Nucl Med. 2013 Jan; 38: (1)50-2.
    View PubMed
  37. Uliel L, Royal HD, Darcy MD, Zuckerman DA, Sharma A, Saad NE. From the angio suite to the gamma-camera: vascular mapping and 99mTc-MAA hepatic perfusion imaging before liver radioembolization--a comprehensive pictorial review. J Nucl Med. 2012 Nov; 53: (11)1736-47.
    View PubMed
  38. Keswani RN, Early DS, Edmundowicz SA, Meyers BF, Sharma A, Govindan R, Chen J, Kohlmeier C, Azar RR. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer. Gastrointest Endosc. 2009 Jun; 69: (7)1210-7.
    View PubMed
  39. Siegel J, Sharma Akash. The locus of origin of augmenting and reducing of visual evoked potentials in rat brain. Physiology & Behavior. 1996; 60(1):287-91. Epub 1996 Jul 11.
    View PubMed